Literature DB >> 26260045

Treatment of Atopic Dermatitis From the Perspective of Traditional Persian Medicine: Presentation of a Novel Therapeutic Approach.

Rasool Choopani1, Mehrzad Mehrbani2, Alireza Fekri3, Mitra Mehrabani4.   

Abstract

There is a strong current trend for using complementary and alternative medications to treat atopic dermatitis. Atopic dermatitis is a common, chronic, pruritic, and inflammatory skin disease. It can have a profound, negative effect on patients' quality of life. Mild cases of atopic dermatitis can be controlled by the application of moisturizers and topical corticosteroids. However, in severe cases, application of immunosuppressive medication is unavoidable but it can have adverse effects. In traditional Persian medicine, diseases similar to resistant atopic dermatitis are treated with whey in combination with decoction of field dodder. Both whey and field dodder have anti-inflammatory properties. Consumption of whey can also aid skin repair, mitigate pruritus, and help combat the high level of stress experienced by patients. Therefore, it is hypothesized that consumption of traditional medicinal treatment of whey with decoction of field dodder can be applied as a complementary treatment for atopic dermatitis.
© The Author(s) 2015.

Entities:  

Keywords:  atopic dermatitis; field dodder; traditional medicine; whey

Mesh:

Substances:

Year:  2015        PMID: 26260045      PMCID: PMC5871194          DOI: 10.1177/2156587215598610

Source DB:  PubMed          Journal:  J Evid Based Complementary Altern Med        ISSN: 2156-5899


  71 in total

Review 1.  Effects of milk-derived bioactives: an overview.

Authors:  N P Shah
Journal:  Br J Nutr       Date:  2000-11       Impact factor: 3.718

2.  The bovine protein alpha-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration, and improves mood under stress.

Authors:  C R Markus; B Olivier; G E Panhuysen; J Van Der Gugten; M S Alles; A Tuiten; H G Westenberg; D Fekkes; H F Koppeschaar; E E de Haan
Journal:  Am J Clin Nutr       Date:  2000-06       Impact factor: 7.045

3.  Palmitoleic acid isomer (C16:1delta6) in human skin sebum is effective against gram-positive bacteria.

Authors:  J J Wille; A Kydonieus
Journal:  Skin Pharmacol Appl Skin Physiol       Date:  2003 May-Jun

4.  A new bioproduction route for a novel antimicrobial peptide.

Authors:  Derrick Kok Sing Tay; Gobinath Rajagopalan; Xiang Li; Yu Chen; Linda H L Lua; Susanna Su Jan Leong
Journal:  Biotechnol Bioeng       Date:  2010-11-17       Impact factor: 4.530

5.  A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology.

Authors:  M Grassberger; T Baumruker; A Enz; P Hiestand; T Hultsch; F Kalthoff; W Schuler; M Schulz; F J Werner; A Winiski; B Wolff; G Zenke
Journal:  Br J Dermatol       Date:  1999-08       Impact factor: 9.302

Review 6.  Partially hydrolyzed 100% whey protein infant formula and atopic dermatitis risk reduction: a systematic review of the literature.

Authors:  Dominik D Alexander; Donald F Schmitt; Nga L Tran; Leila M Barraj; Colleen A Cushing
Journal:  Nutr Rev       Date:  2010-04       Impact factor: 7.110

7.  Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo.

Authors:  M Machnicki; M Zimecki; T Zagulski
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

Review 8.  Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases.

Authors:  Elke C Bornhövd; Walter H C Burgdorf; Andreas Wollenberg
Journal:  Curr Opin Investig Drugs       Date:  2002-05

9.  Low bone mineral density in adult patients with moderate to severe atopic dermatitis.

Authors:  I M Haeck; N A T Hamdy; L Timmer-de Mik; E G W M Lentjes; H J J Verhaar; M J Knol; M S de Bruin-Weller; C A F M Bruijnzeel-Koomen
Journal:  Br J Dermatol       Date:  2009-06-04       Impact factor: 9.302

Review 10.  Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.

Authors:  Evelien Roekevisch; Phyllis Ira Spuls; Denise Kuester; Jacqueline Limpens; Jochen Schmitt
Journal:  J Allergy Clin Immunol       Date:  2013-10-24       Impact factor: 10.793

View more
  4 in total

1.  Fermented rice bran prevents atopic dermatitis in DNCB-treated NC/Nga mice.

Authors:  Evelyn Saba; Chun Hee Lee; Da Hye Jeong; Kija Lee; Tae-Hwan Kim; Seong-Soo Roh; Seung-Hyung Kim; Man Hee Rhee
Journal:  J Biomed Res       Date:  2016-05-20

Review 2.  Review of Medicinal Remedies on Hand Eczema Based on Iranian Traditional Medicine: A Narrative Review Article.

Authors:  Parvin Mansouri; Aleme Khademi; Daryoush Pahlevan; Zahra Memariani; Jale Aliasl; Laila Shirbeigii
Journal:  Iran J Public Health       Date:  2016-08       Impact factor: 1.429

3.  Advanced Effect of Moringa oleifera Bioconversion by Rhizopus oligosporus on the Treatment of Atopic Dermatitis: Preliminary Study.

Authors:  Sang-Sun Hur; Suk-Won Choi; Dong-Ryul Lee; Jong-Hwan Park; Tae-Ho Chung
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-17       Impact factor: 2.629

4.  Ameliorative effects of sea buckthorn oil on DNCB induced atopic dermatitis model mice via regulation the balance of Th1/Th2.

Authors:  Xinxin Wang; Sijia Li; Jiping Liu; Dongning Kong; Xiaowei Han; Ping Lei; Ming Xu; Hongquan Guan; Diandong Hou
Journal:  BMC Complement Med Ther       Date:  2020-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.